These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6289219)

  • 1. Regression patterns of uveal melanomas after proton beam irradiation.
    Wilkes SR; Gragoudas ES
    Ophthalmology; 1982 Jul; 89(7):840-4. PubMed ID: 6289219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results of proton beam irradiated uveal melanomas.
    Gragoudas ES; Seddon JM; Egan K; Glynn R; Munzenrider J; Austin-Seymour M; Goitein M; Verhey L; Urie M; Koehler A
    Ophthalmology; 1987 Apr; 94(4):349-53. PubMed ID: 3035451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton beam irradiation of uveal melanomas. Results of 5 1/2-year study.
    Gragoudas ES; Goitein M; Verhey L; Munzenreider J; Urie M; Suit H; Koehler A
    Arch Ophthalmol; 1982 Jun; 100(6):928-34. PubMed ID: 6284097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current results of proton beam irradiation of uveal melanomas.
    Gragoudas ES; Seddon J; Goitein M; Verhey L; Munzenrider J; Urie M; Suit HD; Blitzer P; Koehler A
    Ophthalmology; 1985 Feb; 92(2):284-91. PubMed ID: 2984625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciliary body and choroidal melanomas treated by proton beam irradiation. Histopathologic study of eyes.
    Seddon JM; Gragoudas ES; Albert DM
    Arch Ophthalmol; 1983 Sep; 101(9):1402-8. PubMed ID: 6311146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraocular inflammation after proton beam irradiation for uveal melanoma.
    Lumbroso L; Desjardins L; Levy C; Plancher C; Frau E; D'Hermies F; Schlienger P; Mammar H; Delacroix S; Nauraye C; Ferrand R; Desblancs C; Mazal A; Asselain B
    Br J Ophthalmol; 2001 Nov; 85(11):1305-8. PubMed ID: 11673294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of proton beam irradiation on uveal melanomas: a comparative study of Ki-67 expression in irradiated versus non-irradiated melanomas.
    Chiquet C; Grange JD; Ayzac L; Chauvel P; Patricot LM; Devouassoux-Shisheboran M
    Br J Ophthalmol; 2000 Jan; 84(1):98-102. PubMed ID: 10611107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of uveal melanoma with iodine 125 plaques or proton beam therapy: indications and comparison of local recurrence rates].
    Desjardins L; Lumbroso L; Levy C; Mazal A; Delacroix S; Rosenwald JC; Dendale R; Plancher C; Asselain B
    J Fr Ophtalmol; 2003 Mar; 26(3):269-76. PubMed ID: 12746603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for metastasis following proton beam irradiation of uveal melanomas.
    Gragoudas ES; Seddon JM; Egan KM; Polivogianis L; Hsieh CC; Goitein M; Verhey L; Munzenrider J; Austin-Seymour M; Urie M
    Ophthalmology; 1986 May; 93(5):675-80. PubMed ID: 3014416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologic examination of ciliary body melanoma treated with proton beam irradiation.
    Ferry AP; Blair CJ; Gragoudas ES; Volk SC
    Arch Ophthalmol; 1985 Dec; 103(12):1849-53. PubMed ID: 3000326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathology of proton beam-irradiated vs enucleated uveal melanomas.
    Saornil MA; Egan KM; Gragoudas ES; Seddon JM; Walsh SM; Albert DM
    Arch Ophthalmol; 1992 Aug; 110(8):1112-8. PubMed ID: 1323252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The time course of irradiation changes in proton beam-treated uveal melanomas.
    Gragoudas ES; Egan KM; Saornil MA; Walsh SM; Albert DM; Seddon JM
    Ophthalmology; 1993 Oct; 100(10):1555-9; discussion 1560. PubMed ID: 8414415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of enucleation after proton beam irradiation of uveal melanoma.
    Egan KM; Gragoudas ES; Seddon JM; Glynn RJ; Munzenreider JE; Goitein M; Verhey L; Urie M; Koehler A
    Ophthalmology; 1989 Sep; 96(9):1377-82; discussion 1382-3. PubMed ID: 2550868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor parameters predict the risk of side effects after ruthenium-106 plaque brachytherapy of uveal melanomas.
    Tarmann L; Wackernagel W; Ivastinovic D; Schneider M; Winkler P; Langmann G
    PLoS One; 2017; 12(8):e0183833. PubMed ID: 28859118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ciliochoroidal melanomas treated with a narrow medical proton beam.
    Brovkina AF; Zarubei GD
    Arch Ophthalmol; 1986 Mar; 104(3):402-4. PubMed ID: 3006648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eye retention after proton beam radiotherapy for uveal melanoma.
    Egger E; Zografos L; Schalenbourg A; Beati D; Böhringer T; Chamot L; Goitein G
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):867-80. PubMed ID: 12605964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laser and proton radiation to reduce uveal melanoma-associated exudative retinal detachments.
    Char DH; Bove R; Phillips TL
    Trans Am Ophthalmol Soc; 2003; 101():53-6; discussion 56-7. PubMed ID: 14971563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rapidly progressing cataract in contact with ciliary body melanoma after proton-beam irradiation].
    Msika LC; Matet A; Dendale R; Vandermeer G; Levy C
    J Fr Ophtalmol; 2019 Mar; 42(3):e115-e116. PubMed ID: 30833006
    [No Abstract]   [Full Text] [Related]  

  • 19. Posterior uveal melanoma in young patients treated with proton beam therapy.
    Vavvas D; Kim I; Lane AM; Chaglassian A; Mukai S; Gragoudas E
    Retina; 2010 Sep; 30(8):1267-71. PubMed ID: 20224468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate of resolution of exudative retinal detachment after plaque radiotherapy for uveal melanoma.
    Harbour JW; Ahmad S; El-Bash M
    Arch Ophthalmol; 2002 Nov; 120(11):1463-9. PubMed ID: 12427058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.